Driving pharmaceutical innovation through scientific excellence and advanced formulation technology
At GRK Pharmaceuticals, research and development is the cornerstone of our mission to deliver high-quality, affordable medicines to patients across India. We invest significantly in innovation, employing experienced pharmaceutical scientists who bring deep expertise in formulation science, analytical chemistry, and drug delivery technology. Our R&D efforts are focused on improving patient outcomes through the development of bioequivalent generics and novel drug delivery systems that enhance therapeutic efficacy, improve bioavailability, and simplify dosing regimens for patients.
Our approach to pharmaceutical development balances scientific rigor with cost-effective manufacturing methodologies, ensuring that every product we bring to market meets the highest quality standards while remaining accessible and affordable. By integrating advanced formulation techniques with lean manufacturing principles, GRK Pharmaceuticals is able to develop differentiated products that serve unmet medical needs without compromising on safety, efficacy, or regulatory compliance. This commitment to science-driven development, combined with our dedication to operational efficiency, positions GRK as a forward-thinking pharmaceutical company ready to meet the evolving healthcare demands of the nation.
Novel drug delivery systems, extended-release formulations, and bioequivalent generics development with focus on improved patient compliance and reduced dosing frequency. Our formulation team leverages advanced polymer science, coating technologies, and multiparticulate systems to create differentiated pharmaceutical products.
Active Pharmaceutical Ingredient synthesis optimization, process chemistry improvements, and cost-effective manufacturing routes for essential molecules. Our API research focuses on developing scalable, environmentally sustainable synthetic processes that reduce production costs while maintaining stringent quality parameters.
Advanced analytical method development & validation using HPLC, GC-MS, dissolution testing, and stability studies per ICH Q1A-Q1E guidelines. Our analytical team ensures robust, reproducible methods that support product development, quality control, and regulatory submissions across all product lines.
Research into sustained-release matrices, enteric-coated systems, and targeted delivery platforms to enhance therapeutic efficacy and reduce adverse effects. Our drug delivery research aims to optimize bioavailability, improve patient compliance, and enable novel therapeutic combinations.
GRK Pharmaceuticals maintains an active innovation pipeline across emerging therapeutic segments
Our product development pipeline is continuously expanding as we identify opportunities in new molecules, new dosage forms, and new therapeutic areas. GRK Pharmaceuticals is committed to addressing gaps in the Indian pharmaceutical market by developing formulations that combine clinical efficacy with patient convenience and affordability.
We are actively exploring emerging therapeutic segments including metabolic disorders, women's health, pediatric formulations, and specialty nutraceuticals. Each pipeline project undergoes rigorous feasibility assessment, formulation optimization, and regulatory pathway evaluation before advancing to commercial scale.
Looking ahead, GRK Pharmaceuticals plans to steadily increase its R&D investment to accelerate the development of differentiated products, strengthen its intellectual property portfolio, and build strategic research collaborations that expand our scientific capabilities and market reach.
A systematic, science-driven approach guides every product from concept through regulatory approval
Prior art analysis & target product profiling
Excipient compatibility & physicochemical evaluation
Prototype design, DoE optimization & pilot batches
HPLC, dissolution & method validation
ICH-compliant accelerated & long-term testing
Technology transfer & commercial batch validation
CDSCO dossier submission & approval